Myelodysplastic Syndromes: Going Gently Into That Good Night (vol 12, pg 795, 2016)

被引：1
作者：
Sekeres, Mikkael A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2016年 / 12卷 / 09期
关键词：
SCORING SYSTEM; TRANSPLANTATION; CARE;
D O I：
10.1200/JOP.2016.015925
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：795 / +
页数：2
相关论文
共 11 条
  • [1] Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
    Bejar, Rafael
    Stevenson, Kristen E.
    Caughey, Bennett
    Lindsley, R. Coleman
    Mar, Brenton G.
    Stojanov, Petar
    Getz, Gad
    Steensma, David P.
    Ritz, Jerome
    Soiffer, Robert
    Antin, Joseph H.
    Alyea, Edwin
    Armand, Philippe
    Ho, Vincent
    Koreth, John
    Neuberg, Donna
    Cutler, Corey S.
    Ebert, Benjamin L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2691 - +
  • [2] Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
    Bhatt, Vijaya Raj
    Steensma, David P.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (09) : 786 - 792
  • [3] A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes:: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
    Cutler, CS
    Lee, SJ
    Greenberg, P
    Deeg, HJ
    Pérez, WS
    Anasetti, C
    Bolwell, BJ
    Cairo, MS
    Gale, RP
    Klein, JP
    Lazarus, HM
    Liesveld, JL
    McCarthy, PL
    Milone, GA
    Rizzo, JD
    Schultz, KR
    Trigg, ME
    Keating, A
    Weisdorf, DJ
    Antin, JH
    Horowitz, MM
    [J]. BLOOD, 2004, 104 (02) : 579 - 585
  • [4] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Finelli, Carlo
    Giagounidis, Aristoteles
    Schoch, Robert
    Gattermann, Norbert
    Sanz, Guillermo
    List, Alan
    Gore, Steven D.
    Seymour, John F.
    Bennett, John M.
    Byrd, John
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    [J]. LANCET ONCOLOGY, 2009, 10 (03) : 223 - 232
  • [5] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    [J]. BLOOD, 1997, 89 (06) : 2079 - 2088
  • [6] Revised International Prognostic Scoring System for Myelodysplastic Syndromes
    Greenberg, Peter L.
    Tuechler, Heinz
    Schanz, Julie
    Sanz, Guillermo
    Garcia-Manero, Guillermo
    Sole, Francesc
    Bennett, John M.
    Bowen, David
    Fenaux, Pierre
    Dreyfus, Francois
    Kantarjian, Hagop
    Kuendgen, Andrea
    Levis, Alessandro
    Malcovati, Luca
    Cazzola, Mario
    Cermak, Jaroslav
    Fonatsch, Christa
    Le Beau, Michelle M.
    Slovak, Marilyn L.
    Krieger, Otto
    Luebbert, Michael
    Maciejewski, Jaroslaw
    Magalhaes, Silvia M. M.
    Miyazaki, Yasushi
    Pfeilstoecker, Michael
    Sekeres, Mikkael
    Sperr, Wolfgang R.
    Stauder, Reinhard
    Tauro, Sudhir
    Valent, Peter
    Vallespi, Teresa
    van de Loosdrecht, Arjan A.
    Germing, Ulrich
    Haase, Detlef
    [J]. BLOOD, 2012, 120 (12) : 2454 - 2465
  • [7] Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
    Koreth, John
    Pidala, Joseph
    Perez, Waleska S.
    Deeg, H. Joachim
    Garcia-Manero, Guillermo
    Malcovati, Luca
    Cazzola, Mario
    Park, Sophie
    Itzykson, Raphael
    Ades, Lionel
    Fenaux, Pierre
    Jadersten, Martin
    Hellstrom-Lindberg, Eva
    Gale, Robert Peter
    Beach, C. L.
    Lee, Stephanie J.
    Horowitz, Mary M.
    Greenberg, Peter L.
    Tallman, Martin S.
    DiPersio, John F.
    Bunjes, Donald
    Weisdorf, Daniel J.
    Cutler, Corey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) : 2662 - +
  • [8] Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS (vol 28, pg 1033, 2014)
    List, A. F.
    Bennett, J. M.
    Sekeres, M. A.
    Skikne, B.
    Fu, T.
    Shammo, J. M.
    Nimer, S. D.
    Knight, R. D.
    Giagounidis, A.
    [J]. LEUKEMIA, 2015, 29 (12) : 2452 - 2452
  • [9] Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 Study Rationale, Design, and Methods
    Saber, Wael
    Le Rademacher, Jennifer
    Sekeres, Mikkael
    Logan, Brent
    Lewis, Moira
    Mendizabal, Adam
    Leifer, Eric
    Appelbaum, Frederick R.
    Horowitz, Mary M.
    Nakamura, Ryotaro
    Cutler, Corey S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (10) : 1566 - 1572
  • [10] Myelodysplastic Syndromes: Going Gently Into That Good Night (vol 12, pg 795, 2016)
    Sekeres, Mikkael A.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (09) : 795 - +
12